Product Details
Product Name:
ND-322 HCl |
CAS No.:
1333379-23-9 |
Purity:
98.14% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | ND-322 HCl |
Description | ND-322 HCl (ND 322 Hydrochloride) is a selective inhibitor of MT1-MMP and MMP2 and reduces in vitro melanoma cell growth, migration and invasion. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 45 mg/mL (125.74 mM)
|
Keywords | ND-322 HCl | ND 322 HCl |
Inhibitors Related | Stigmasterol | Ethyl gallate | Doxycycline (hyclate) | Chondroitin sulfate | Astragaloside IV | Doxycycline | Edaravone | Glucosamine | Triolein | Arctigenin | Fenofibric acid | Glucosamine sulfate |
Related Compound Libraries | Bioactive Compound Library | Protease Inhibitor Library | Inhibitor Library | Anti-Fibrosis Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:59556-17-1
$110.00 / 1mg
-
CAS:1807453-83-3
$1500.00 / 10mg
-
CAS:1194574-33-8
$195.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$293.00/1mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 |
|
$77.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |
|
$0.00/1KG |
|
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
|
2021-03-11 |